DevicePMAs@therightstef:P040024_S073 JSONTXT

{"project":"PMA_MER","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25425"},{"id":"T2","span":{"begin":49,"end":55},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62103"},{"id":"T3","span":{"begin":73,"end":85},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C51982"},{"id":"T4","span":{"begin":95,"end":99},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25240"},{"id":"T5","span":{"begin":100,"end":106},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C12701"},{"id":"T6","span":{"begin":110,"end":121},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25239"},{"id":"T7","span":{"begin":122,"end":130},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C33645"},{"id":"T8","span":{"begin":139,"end":149},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C54657"},{"id":"T9","span":{"begin":153,"end":161},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C61376"},{"id":"T10","span":{"begin":165,"end":171},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C70667"},{"id":"T11","span":{"begin":172,"end":178},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C161327"},{"id":"T12","span":{"begin":233,"end":245},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C13353"},{"id":"T13","span":{"begin":265,"end":277},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C51982"},{"id":"T14","span":{"begin":282,"end":287},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C13070"},{"id":"T15","span":{"begin":305,"end":315},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C54657"},{"id":"T16","span":{"begin":339,"end":346},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C70749"},{"id":"T17","span":{"begin":381,"end":384},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25150"}],"text":"Approval for restylane lyft with lidocaine. this device is indicated for implantation into the deep dermis to superficial subcutis for the correction of moderate to severe facial folds and wrinkles, such as nasolabial folds; and for subcutaneous to supraperiosteal implantation for cheek augmentation and correction of age-related midface contour deficiencies in patients over the age of 21."}

{"project":"consensus_PMA_Age_Indications","denotations":[{"id":"T1","span":{"begin":372,"end":390},"obj":"age_range"},{"id":"T2","span":{"begin":372,"end":376},"obj":"age_end"},{"id":"T3","span":{"begin":388,"end":390},"obj":"age_start"}],"text":"Approval for restylane lyft with lidocaine. this device is indicated for implantation into the deep dermis to superficial subcutis for the correction of moderate to severe facial folds and wrinkles, such as nasolabial folds; and for subcutaneous to supraperiosteal implantation for cheek augmentation and correction of age-related midface contour deficiencies in patients over the age of 21."}

{"project":"age_PMA_annotations","denotations":[{"id":"T1","span":{"begin":388,"end":390},"obj":"population"}],"text":"Approval for restylane lyft with lidocaine. this device is indicated for implantation into the deep dermis to superficial subcutis for the correction of moderate to severe facial folds and wrinkles, such as nasolabial folds; and for subcutaneous to supraperiosteal implantation for cheek augmentation and correction of age-related midface contour deficiencies in patients over the age of 21."}

{"project":"PMA_age_indications","denotations":[{"id":"T2","span":{"begin":372,"end":376},"obj":"age_end"},{"id":"T1","span":{"begin":372,"end":390},"obj":"age_range"},{"id":"T3","span":{"begin":388,"end":390},"obj":"age_start"}],"text":"Approval for restylane lyft with lidocaine. this device is indicated for implantation into the deep dermis to superficial subcutis for the correction of moderate to severe facial folds and wrinkles, such as nasolabial folds; and for subcutaneous to supraperiosteal implantation for cheek augmentation and correction of age-related midface contour deficiencies in patients over the age of 21."}

{"project":"Age_blah","denotations":[{"id":"T1","span":{"begin":388,"end":390},"obj":"age_start"},{"id":"T2","span":{"begin":372,"end":376},"obj":"age_end"},{"id":"T3","span":{"begin":372,"end":390},"obj":"age_range"}],"text":"Approval for restylane lyft with lidocaine. this device is indicated for implantation into the deep dermis to superficial subcutis for the correction of moderate to severe facial folds and wrinkles, such as nasolabial folds; and for subcutaneous to supraperiosteal implantation for cheek augmentation and correction of age-related midface contour deficiencies in patients over the age of 21."}

{"project":"updated_tagging_age_PMA_annotations","denotations":[{"id":"T1","span":{"begin":372,"end":390},"obj":"age_range"},{"id":"T2","span":{"begin":372,"end":376},"obj":"age_end"},{"id":"T3","span":{"begin":388,"end":390},"obj":"age_start"}],"text":"Approval for restylane lyft with lidocaine. this device is indicated for implantation into the deep dermis to superficial subcutis for the correction of moderate to severe facial folds and wrinkles, such as nasolabial folds; and for subcutaneous to supraperiosteal implantation for cheek augmentation and correction of age-related midface contour deficiencies in patients over the age of 21."}